← Back to Search

Corticosteroid

Methylprednisolone (MPA) for Shoulder Pain

Phase 4
Waitlist Available
Led By Tyler Brolin, MD
Research Sponsored by Campbell Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-injection day 1 through 7
Awards & highlights

Study Summary

This trial compares the FLARE reaction rates to shoulder injections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-injection day 1 through 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-injection day 1 through 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of a Flare Reaction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: methylprednisolone acetate (MPA)Experimental Treatment1 Intervention
subacromial or glenohumeral shoulder injection
Group II: triamcinolone acetonide (TA)Active Control1 Intervention
subacromial or glenohumeral shoulder injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methylprednisolone
FDA approved

Find a Location

Who is running the clinical trial?

Campbell ClinicLead Sponsor
10 Previous Clinical Trials
1,401 Total Patients Enrolled
Tyler Brolin, MDPrincipal InvestigatorCampbell Clinic
1 Previous Clinical Trials
82 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~80 spots leftby Apr 2025